Chicago Partners Investment Group’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
9,330
+4,751
+104% +$792K 0.03% 483
2026
Q1
$887K Buy
4,579
+3,317
+263% +$834K 0.02% 595
2025
Q4
$343K Sell
1,262
-73
-5% -$22.8K 0.01% 958
2025
Q3
$433K Buy
1,335
+566
+74% +$177K 0.01% 778
2025
Q2
$220K Buy
+769
New +$222K 0.01% 999

Other funds holding PODD

Chicago Partners Investment Group's PODD Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Insulet (PODD) stake by 104% in Q2 2026, buying an estimated $792K and bringing the position to 9,330 shares worth $1.48M. The position accounts for 0.03% of the portfolio, ranked #483.

Chicago Partners Investment Group first reported a position in PODD in Q2 2025 and has held it in 5 quarters since. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Chicago Partners Investment Group held 9,330 shares of Insulet worth $1.48M as of Q2 2026.
  • Chicago Partners Investment Group bought 4,751 Insulet shares in Q2 2026, an estimated $792K.
  • Insulet made up 0.03% of Chicago Partners Investment Group's portfolio in Q2 2026, its #483 holding.
  • Chicago Partners Investment Group first reported a position in Insulet in Q2 2025 and has held it in 5 quarters since.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.